BSCL2/seipin regulates adipogenesis through actin cytoskeleton remodelling

Adipogenesis involves complex cellular processes, including lipid droplet formation and cytoskeletal changes. Prior research has shown that seipin plays a role in lipid homeostasis, but its exact mechanism in adipocyte development remains unclear. It was already known that seipin prevents lipid droplet formation in non-adipocytes but promotes it in developing adipocytes. However, the role of seipin in actin cytoskeleton remodelling during adipogenesis was not fully understood. This gap motivated further investigation into how seipin interacts with other proteins to influence adipogenesis. No prior work had resolved the specific interaction between seipin and 14-3-3β or cofilin-1. Understanding these interactions could clarify how cytoskeletal changes contribute to adipocyte development. This uncertainty drove the current study to explore the molecular pathways involved in actin remodelling during adipogenesis. The findings aim to bridge the knowledge gap between seipin function and cytoskeletal dynamics in adipogenesis.

The aim of this study was to investigate how seipin regulates adipogenesis through interactions with other proteins. The specific problem addressed is the unclear mechanism by which seipin influences cytoskeletal changes during adipocyte development. The researchers propose that seipin interacts with 14-3-3β and cofilin-1 to modulate actin cytoskeleton remodelling. This study sought to determine whether these interactions are necessary for proper adipogenesis. The motivation stems from the need to understand the molecular basis of adipocyte differentiation. The study focused on the role of seipin in recruiting cofilin-1 via 14-3-3β. By examining the effects of gene knockdowns and actin mutants, the researchers aimed to clarify the functional relationship between these proteins. The findings could provide insights into the cytoskeletal changes required for adipogenesis.

The study used protein interaction assays to identify seipin's binding partners, including 14-3-3β and cofilin-1. Adipogenesis was tracked in 3T3-L1 cells through differentiation protocols. Gene expression levels of 14-3-3β were measured during adipogenesis using quantitative methods. Knockdown experiments were performed to assess the role of seipin, 14-3-3β, and cofilin-1 in adipogenesis. Cytoskeletal changes were observed using fluorescence microscopy to track actin structures. A severing-resistant actin mutant was introduced to test its impact on adipogenesis. The study also evaluated the spatiotemporal recruitment of cofilin-1 by 14-3-3β during differentiation. These methods allowed the researchers to determine the functional role of seipin in actin remodelling.

Seipin interacts with 14-3-3β through its N- and C-termini. Expression of 14-3-3β increases during adipogenesis. Deletion of 14-3-3β leads to defective adipogenesis without affecting key transcription factors. Cofilin-1 is an interacting partner of 14-3-3β. Cofilin-1 is recruited by 14-3-3β in the cytoplasm during differentiation. Adipogenesis involves actin cytoskeleton remodelling from stress fibres to cortical structures. Knockdown of cofilin-1, 14-3-3β, or seipin impairs adipocyte development. Cells with knockdowns maintain stress fibres but lack cortical actin structures.

The authors propose that seipin regulates adipogenesis by recruiting cofilin-1 through 14-3-3β. This interaction facilitates actin cytoskeleton remodelling during adipocyte development. The study suggests that actin remodelling is required for proper adipogenesis. The findings indicate that seipin, 14-3-3β, and cofilin-1 work together to influence cytoskeletal changes. Knockdown of any of these proteins leads to impaired adipogenesis. The results support the idea that cytoskeletal changes are necessary for adipocyte differentiation. The study does not suggest that these proteins are essential for lipid droplet formation in non-adipocytes. The authors conclude that seipin's role in adipogenesis is linked to its ability to modulate actin structures.